期刊文献+

CD44v6 E-cad表达与早期宫颈鳞癌淋巴结转移的关系

CD44v6 and E-cadherin expression′s relation with lymph node metastasis of squamous cervical carcinoma
下载PDF
导出
摘要 目的研究CD44v6与E-钙黏附素(E-cad)在早期宫颈鳞癌中的表达,探讨其在淋巴结转移中的作用及临床意义。方法采用反转录聚合酶链反应(RT-PCR)与免疫组织化学法对21例正常宫颈上皮、63例无淋巴结转移宫颈鳞癌、23例有淋巴结转移宫颈鳞癌标本中CD44v6、E-cad的mRNA和蛋白表达进行检测。结果宫颈鳞癌组织中CD44v6mRNA的表达高,而在正常宫颈几乎不表达;E-cad的mRNA在正常宫颈组织表达高而在宫颈鳞癌表达低,有淋巴结转移和无淋巴结转移的宫颈鳞癌组织差异均有统计学意义(P<0.05)。CD44v6蛋白在宫颈鳞癌表达增高而E-cad蛋白表达降低,且在有转移和无转移的宫颈鳞癌组织中差异有统计学意义(P<0.05),且CD44v6和E-cad的表达与淋巴结转移相关(P<0.05)。结论CD44v6、E-cad通过改变早期宫颈鳞癌细胞的黏附力而分别发挥了促进和抑制宫颈鳞癌淋巴结转移的作用,可作为评估预后的生物学指标。 Objective To study the expression and clinical significance of CD44v6 and E-cadherin(E-cad) in squamous cervical carcinoma. Methods Twenty-one cases of normal cervical tissue, 63 cases of squamous cervical carcinoma without lymph node metastasis,23 cases of squamous cervical carcinoma with lymph node metastasis were detected for the mRNA and protein expression of CD44v6 and E-cad by means of RT-PCR and immunohistochemical method. Results CD44v6 was negatively expressed in normal cervical epithelium,but the expression of CD44v6 went up in squamous cervical carcinoma,transepithelial carcinoma of cervix uteri-invasive carcinoma of cervix uteri. CD44v6 had positive correlation with clinical staging and histological grading of the carcinoma.The positive rate of CD44v6 in people with lymph node metastasis was higher than that in those without lymph node metastasis. Conclusion The positive expression of CD44v6 has close relationship with lymph node metastasis. Expression of CD44v6 is important for evaluating the prognosis of cervical cancer.
出处 《中国药物与临床》 CAS 2005年第10期747-750,共4页 Chinese Remedies & Clinics
基金 太原市科委攻关基金资助项目(并科学2003064)
  • 相关文献

参考文献14

  • 1Waggoner SE.Cervical cancer. Lancet,2003,361:2217-2225.
  • 2Hurtubise A,Momparler RL. Evaluation of antineoplastic action of 5-Aza-2'-deoxycytidine (dacogen) and docetaxel (taxotere) on human breast,lung and prostate carcinoma cell lines. Anticancer Drugs,2004,15(2): 161-167.
  • 3Kainz C,Kohlberger P,Sliutz G,et al. Splice variants of CD44 inhuman cervical cancer stage Ⅰ b to Ⅱb. Gynecol Oncol, 1995,57 (3) :383-387.
  • 4Callagy G,OGrady A,Butler D,et al. Expression of CD44 in uterine cervical squamous neoplasia:a predictor of microinvasion. Gynecol Oncol, 2000,76( 1 ): 73-79.
  • 5陈雅卿,郑爱文,张谷.CD44v6在宫颈癌中的表达及其意义[J].中国肿瘤,2002,11(8):485-486. 被引量:5
  • 6Christofori G.Changing neighbours, changing behaviour :cell adhesion molecule-mediated signalling during tumour progression. EMBO J,2003,22(10) :2318-2123.
  • 7Jothy S.CD44 and its partners in metastasis. Clin Exp Metastasis, 2003,20(3): 195-201.
  • 8Marhaba R,Zoller M.CD44 in cancer progression:adhesion, migration and growth regulation.J Mol Histol, 2004,35 ( 3 ): 211 - 231.
  • 9Nawrocki-Raby B,Gilles C,Polette M,et al.E-cadherin mediates MMP down-regulation in highly invasive bronchial tumor cells. Am J Pathol,2003,163:653-661.
  • 10Poon RT,Fan ST,Wong J.Clinical significance of angiogenesis in gastrointestinal cancers:a target for novel prognostic and therapeutic approaches. Ann Surg, 2003,238( 1 ): 9-28.

二级参考文献10

  • 1[1]Shinohara A, Yokoyama Y, Wan XY, et al. Cytoplsmic/nuclear expression without mutation of exon 3 of the β-catenin gene is frequent in the development of the neoplasm of the uterine cervix[J]. Gynecol Oncol, 2001, 82(3): 450-455.
  • 2[2]Moon HS, Choi EA, Park HY, et al. Expression and tyrosine phosphorylation of E-cadherin, β and γ catenin and epidermal growth factor receptor in cervical cancer cells[J]. Gynecol Oncol, 2001,81(3):355-359.
  • 3[3]Moon HS, Kim JI, Son YS, et al. E-cadherin expression in cervical Carcinogenesis[J]. Kor J Obestet Gynecol, 1997, 40(3):548-557.
  • 4[4]Davies BR, Worsley SD, Ponder BAJ. Expression of E-cadherin, α-catenin and β-catenin in normal ovarian surface epithelium and epithelial ovarian cancers[J]. Histopathology, 1998, 32(1): 69-80.
  • 5[5]Ara T, Deyama Y, Yoshimura Y, et al. Memberane type1-matrix metaloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade[J]. Cancer Lett, 2000, 157 (1):115-121.
  • 6Kazou T. Expression of CD44 variant exons in colorectal cancer and its relationship metastasis [J]. Jpn J Cancer Res, 1995, 86:292.
  • 7Speiser P, Kridelka F, Tempfer C, et al. CD44v6 expression is an independment prognostic factor in node-negtive FIGO stage Ⅰ b cervical carcinoma[J]. Int J Gynecol Cancer,1999, 2:160.
  • 8Ayhan A, Baykal C, AL A, et al. Altered CD44 variant 6 expression in FIGO stage Ⅰ b cervical carcinoma[J]. Gyncol Oncol, 2001,83:569- 574.
  • 9Kainz C, Khlberger D, Sliutz G, et al. Splice variants of CD44 in human cervical cancer stage Ⅰ b to Ⅱ b[J]. Gyncol Oncol, 1995,57:383- 387.
  • 10Droll A, Nicholas HB, Facukh SM, et al. Adhesive interactions between alternatively spliced CD44 isoforms[J]. J Bio Chem, 1995, 270:11567.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部